Dry Eye Syndrome Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The Dry Eye Syndrome Market size is expected to grow at an annual average of 4% during 2021-2027. Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture in the surface of the eyes of an infected person. It is a commonly occurring disease that can affect almost anyone. Various symptoms of dry eye syndrome include tingling, stinging, red eyes, eye strain, itchy eyes, and photophobia. In addition to this, dry eye syndrome can be a symptom of dry eye syndrome as it overstimulates its production. Moisture component in tears to reduce dryness. There are many factors that can cause dry eye, including excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, and hormone replacement therapy.

The following segmentation are covered in this report:

By Product

• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Other

By Disease Type

• Evaporative
• Aqueous

By Drug Type

• Anti-inflammatory Drugs
• Lubricant Eye Drops
• Autologous Serum Eye Drops

 Company Profile

• Allergan Plc.
• Novartis AG
• Otsuka Pharmaceutical Co.,Ltd.
• Santen Pharmaceutical Co Ltd.
• Bausch Health Companies Inc.
• Akorn, Inc.
• Johnson & Johnson, Inc.
• Thea Pharmaceuticals Limited
• OASIS Medical
• Altaire Pharmaceuticals Inc.
• Boiron USA
• Similasan Corporation
• Scope Ophthalmics Ltd.
• Reckitt Benckiser Group PLC
• Medicom Healthcare Ltd
• FDC Limited.
• Lupin Limited
• Jamjoom Pharmaceuticals Co.
• Sentiss Pharma Private limited

Scope of the report

The research study analyses the Dry Eye Syndrome Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Dry Eye Syndrome Market Report

• What was the Dry Eye Syndrome Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Dry Eye Syndrome Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.